Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 11 studies | 50% ± 23% | |
| glutamatergic neuron | 11 studies | 64% ± 22% | |
| endothelial cell | 10 studies | 32% ± 14% | |
| oligodendrocyte precursor cell | 9 studies | 31% ± 8% | |
| neuron | 6 studies | 33% ± 13% | |
| interneuron | 6 studies | 64% ± 16% | |
| endothelial cell of lymphatic vessel | 6 studies | 21% ± 6% | |
| fibroblast | 6 studies | 23% ± 11% | |
| retinal ganglion cell | 5 studies | 61% ± 35% | |
| adipocyte | 4 studies | 34% ± 8% | |
| pericyte | 4 studies | 28% ± 8% | |
| GABAergic interneuron | 3 studies | 53% ± 10% | |
| granule cell | 3 studies | 39% ± 23% | |
| GABAergic amacrine cell | 3 studies | 28% ± 7% | |
| endothelial cell of vascular tree | 3 studies | 35% ± 11% | |
| retinal pigment epithelial cell | 3 studies | 54% ± 20% | |
| type I pneumocyte | 3 studies | 19% ± 2% | |
| astrocyte | 3 studies | 38% ± 29% | |
| smooth muscle cell | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 265.58 | 2626 / 2642 | 85% | 5.61 | 599 / 705 |
| lung | 94% | 77.45 | 543 / 578 | 11% | 0.35 | 126 / 1155 |
| skin | 43% | 21.27 | 770 / 1809 | 59% | 1.37 | 277 / 472 |
| spleen | 100% | 148.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| breast | 90% | 67.26 | 415 / 459 | 5% | 0.14 | 59 / 1118 |
| adipose | 92% | 70.02 | 1109 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 66% | 32.84 | 638 / 966 | 25% | 0.92 | 132 / 527 |
| thymus | 80% | 49.96 | 520 / 653 | 1% | 0.01 | 4 / 605 |
| kidney | 72% | 39.45 | 64 / 89 | 5% | 0.07 | 41 / 901 |
| adrenal gland | 60% | 37.18 | 155 / 258 | 12% | 0.50 | 28 / 230 |
| uterus | 65% | 27.63 | 111 / 170 | 5% | 0.15 | 25 / 459 |
| prostate | 59% | 28.05 | 145 / 245 | 2% | 0.04 | 9 / 502 |
| stomach | 30% | 12.35 | 107 / 359 | 27% | 1.35 | 77 / 286 |
| esophagus | 39% | 15.40 | 560 / 1445 | 8% | 0.40 | 15 / 183 |
| heart | 44% | 16.70 | 381 / 861 | 0% | 0 | 0 / 0 |
| bladder | 19% | 7.24 | 4 / 21 | 10% | 0.33 | 51 / 504 |
| ovary | 22% | 7.73 | 40 / 180 | 3% | 0.06 | 15 / 430 |
| blood vessel | 20% | 8.18 | 265 / 1335 | 0% | 0 | 0 / 0 |
| liver | 3% | 1.45 | 7 / 226 | 11% | 0.24 | 44 / 406 |
| muscle | 5% | 1.46 | 38 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.06 | 3 / 80 |
| pancreas | 3% | 0.79 | 10 / 328 | 1% | 0.02 | 1 / 178 |
| peripheral blood | 2% | 0.53 | 14 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0097091 | Biological process | synaptic vesicle clustering |
| GO_0032228 | Biological process | regulation of synaptic transmission, GABAergic |
| GO_0007269 | Biological process | neurotransmitter secretion |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0030672 | Cellular component | synaptic vesicle membrane |
| GO_0008021 | Cellular component | synaptic vesicle |
| GO_0098850 | Cellular component | extrinsic component of synaptic vesicle membrane |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | SYN3 |
| Protein name | Synapsin III Synapsin-3 (Synapsin III) |
| Synonyms | |
| Description | FUNCTION: May be involved in the regulation of neurotransmitter release and synaptogenesis. |
| Accessions | ENST00000412575.1 ENST00000441821.5 Q4TT46 ENST00000358763.7 A6ZJ82 Q17R54 O14994 |